About Marvelous

We believe science is the most important infrastructure of the next century.

Marvelous was founded on a simple conviction: the world's most critical industries face existential pressure. The science to fix them exists in European labs. We built a platform to make sure those breakthroughs actually reach the world.


"Europe is great at making science out of money. Now let's make money out of science."
The Team
Chris Heyer

Chris Heyer

GENERAL PARTNER

Founded & scaled 5 startups with 2 exits. Angel Investor. CIO at Hypoport (MDAX). Built several CVCs for OBI and Vonovia among others. Knows what it takes to commercialize from the inside. Strategy and vision behind the Marvelous platform.

Philipp Buddemeier

Philipp Buddemeier

GENERAL PARTNER

Bain · McKinsey · Accenture. Founder of Better Earth. Co-founded a circular economy incubator in 2012. Leads the Catalyst — the engine that turns science into revenue.

Lian Michelson

Lian Michelson

GENERAL PARTNER

GP at Vala Capital. Founded United Ocean Fund. Tech founder and operator. Angel investor with exits. Morgan Stanley fixed income trader. MEng. Leads the Marvelous Ventures Fund I investment team.

Raffael Hodi

Raffael Hodi

FOUNDER'S ASSOCIATE

Austrian ecosystem native with experience across Speedinvest and Austria Wirtschaftsservice, combining startup exposure with a strong academic focus on finance, economics, and venture-building.

Anju Negi

Anju Negi

FOUNDER'S ASSOCIATE

DeepTech and venture ecosystem operator with experience across Transition VC and early-stage founder support, combining market-building exposure with a strong academic foundation from ESCP.

Jannis Duckek

Jannis Duckek

VISITING ANALYST

Industrial innovation and sustainability-focused operator with experience across R&D, business development, and consulting, combining technical depth with venture-building exposure from ESCP.


Venture Partners
Christian Schad

Christian Schad

OPERATIONS & FINANCE

Co-founder & former Managing Partner at Planet A Ventures. Founded B2B tech company, scaled internationally, exited via M&A. 25+ years scaling ventures.

Arne Morteani, PhD

Arne Morteani, PhD

DEALFLOW & SCIENCE DD

Founding GP at Kiko Ventures. 14 years at ETF Partners leading ClimateTech investments. PhD Physics/Materials Science, Cambridge. Co-founded European Venture Capital Network.

Michael Kirch, PhD

Michael Kirch, PhD

DEALFLOW

LP in 14 early-stage VC funds since 2006. Commodities Strategist at Goldman Sachs. Co-founded B2B SaaS startup, 9-figure exit in 2021. PhD Mathematics, Humboldt.


Science Team
Dr. Daniel Auriel

Dr. Daniel Auriel

CHEMICAL EXPERT

PhD Chemistry, UC Louvain. Executive positions at Bayer.

Anja Leissner

Anja Leissner

FOOD EXPERT

Biotech R&D background. Foodtech company exit.

Lia Carlucci

Lia Carlucci

FOOD EXPERT

Nutrition expertise. Founded Germany's largest food innovation think tank.

Catherine Tubb

Catherine Tubb

HEAD OF SCIENCE

Sustainability research expert focused on food systems, alternative proteins and technology-driven disruption in agriculture.


2
Engines: Capital + Catalyst
2
Investment Strategies
60+
Industrial partners
EU
Pan-European focus
Our Values

Science first

Every investment decision starts with the technology. We validate the science before we evaluate the market, because defensibility comes from what is real, not what is projected.

Long-term partnership

DeepTech takes time. We sign up for the full journey. From first results to industrial scale. Our funds structure is designed to match the reality of scientific commercialization.

Impact by design

Marvelous Ventures Fund 1: Article 9 SFDR. Carry linked to impact KPIs at exit. We believe the companies that solve the most important industrial problems will also generate the best returns.

Network as a moat

Capital is a commodity. Access to the right industrial partners is not. Our Catalyst network, with 60+ industry partners, 10+ research institutions and universities is the durable advantage we bring to every portfolio company.

Radical transparency

We tell founders what we actually think. About their science, their strategy, their team, and their prospects. Clear, honest feedback beats comfortable silence.

Speed where it matters

First meeting to term sheet in 3–4 weeks for opportunities that meet our thesis. We don't waste founder time with endless process when the answer is already clear.


Building something
extraordinary?

We would love to meet the people behind the science.

Get in TouchExplore Capital